NeuroGenesis is a clinical-stage cellular therapy company that focuses on utilizing a proprietary subpopulation of bone marrow stem cells. These cells are specifically selected and enhanced to become remyelinating and regenerative biofactory cells. The company's platform, NG CELL technology, is specifically designed to treat central nervous system diseases, such as progressive multiple sclerosis and amyotrophic lateral sclerosis.